Ontology highlight
ABSTRACT:
SUBMITTER: Amstutz U
PROVIDER: S-EPMC5760397 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
Clinical pharmacology and therapeutics 20171120 2
The purpose of this guideline is to provide information for the interpretation of clinical dihydropyrimidine dehydrogenase (DPYD) genotype tests so that the results can be used to guide dosing of fluoropyrimidines (5-fluorouracil and capecitabine). Detailed guidelines for the use of fluoropyrimidines, their clinical pharmacology, as well as analyses of cost-effectiveness are beyond the scope of this document. The Clinical Pharmacogenetics Implementation Consortium (CPIC<sup>®</sup> ) guidelines ...[more]